Enhancement of Ischemic Flap Survival by Prefabrication with Transfer of Exogenous PDGF Gene

ABSTRACT

Treatment of skin flaps by means of gene therapy has been introduced recently as a novel approach to enhance viability of ischemic skin flaps. Transfer of the platelet-derived growth factor (PDGF) to enhance survival of the ischemic skin flap has not been explored. In this study, the authors investigated the effect of the transfer of the PDGF cDNA on survival and vascularity of the ischemic random flap in a rat model, and compared the effects of PDGF gene therapy to those of vascular endothelial growth factor (VEGF) gene therapy. A total of 45 adult Sprague-Dawley rats were randomly divided into four groups. The PDGF gene therapy group (n = 10) received the plasmid containing the PDGF cDNA with liposome injected to the dermis of the flap. A saline control group (n = 10) received physiologic saline only, and the vector control group (n = 10) received liposome plus vector without the PDGF gene segment. In the fourth group (n = 15), the VEGF gene was transferred to the flap. Seven days later, a dorsal random flap including the injection area was raised. One rat each from the saline and vector control groups died during the study period and were excluded. The viability of the flap and vascularity within the flaps were assessed 7 days after flap elevation. The PDGF plasmid-treated flaps had significantly greater survival area (60.8 ± 7.8 percent) compared with the flaps treated with saline (52.3 ± 5.0 percent) and those treated with liposome and vector (50.7 ± 5.9 percent). PDGF gene therapy had effects on survival of the flap similar to VEGF gene therapy (57.6 ± 5.2 percent, after transfer of VEGF cDNA). Neovascularization with the flap tissues was confirmed by immunohistochemical staining of von Willebrand factor, a marker specific for angiogenesis. The number of newly-formed blood vessels in the transgenic flaps was significantly greater than that of the vessels in the flaps receiving the saline. The findings of this study indicate that transfer of the PDGF cDNA effectively enhances neovascularization of the ischemic skin flap and increases the viability of the flap, and transfer of the PDGF gene is as efficient as transfer of the VEGF gene in improving viability of the skin flap. This study suggests that PDGF gene therapy may be a novel strategy for the treatment of ischemic skin flaps.

KEYWORDS

Skin flap - ischemia - gene therapy - neovascularization - immunohistochemistry

REFERENCES

• 1 Abbase E A, Shenaq S M, Spira M, e-Falaky M H. Prefabricated flaps: experimental and clinical review.  Plast Reconstr Surg. 1995;  96 1218-1225
• 2 Khouri R K, Upton J, Shaw W W. Prefabrication of composite free flaps through staged microvascular transfer: an experimental and clinical study.  Plast Reconstr Surg. 1991;  87 108-115
• 3 Komuro Y, Takato T, Yamada A, Yonehara Y. Experimental study of prefabricated flaps using vein grafts.  J Reconstr Microsurg. 1993;  9 373-379
• 4 Pang C Y, Forrest C R, Morris S F. Pharmacological augmentation of skin flap viability: a hypothesis to mimic the surgical delay phenomenon or a wishful thought.  Ann Plast Surg. 1989;  22 293-306
• 5 Knight K R. Review of postoperative pharmacological infusion in ischemic skin flaps.  Microsurgery. 1994;  15 675-684
• 6 Ishiguro N, Yabe Y, Shimizu T, Iwata H, Miura T. Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats.  Ann Plast Surg. 1994;  32 356-360
• 7 Nall A V, Brownlee R E, Colvin C P et al.. Transforming growth factor β1 improves wound healing and random flap survival in normal and irradiated rats.  Arch Otolaryngol Head Neck Surg. 1996;  122 171-177
• 8 Kryger Z, Dogan T, Zhang F et al.. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat.  Ann Plast Surg. 1999;  43 172-178
• 9 Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver W C, Buncke H J. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration.  Br J Plast Surg. 2000;  53 234-239
• 10 Walls C M, Gregory C R, Beck L S. Effects of growth factors and L-arginine on ischemic skin flaps in rats.  Vet Surg. 1995;  24 484-491
• 11 Taub P J, Marmur J D, Zhang W X et al.. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps.  Plast Reconstr Surg. 1998;  102 2003-2009
• 12 Taub P J, Marmur J D, Zhang W X et al.. Effect of time on the viability of ischemic skin flaps treated with vascular endothelial growth factor (VEGF) cDNA.  J Reconstr Microsurg. 1998;  14 387-390
• 13 Lubiatowski P, Goldman C K, Gurunluoglu R, Carnevale K, Siemionow M. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy.  Plast Reconstr Surg. 2002;  109 1986-1993
• 14 O’Toole G, MacKenzie D, Lindeman R et al.. Vascular endothelial growth gene therapy in ischemic rat skin flaps.  Br J Plast Surg. 2002;  55 55-58
• 15 Gurunluoglu R, Ozer K, Skugor B, Lubiatowski P, Carnevale K, Siemionow M. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene.  Ann Plast Surg. 2002;  49 161-169
• 16 Neumeister M W, Song Y H, Mowlavi A, Suchy H, Mathur A. Effects of liposome-mediated gene transfer of VEGF in ischemic rat gracillis muscle.  Microsurgery. 2001;  21 58-62
• 17 Liu P Y, Tong W, Liu K et al.. Liposome-mediated transfer of vascular endothelial growth factor cDNA augments survival of random-pattern skin flaps in the rat.  Wound Repair Regen. 2004;  12 80-85
• 18 Brown D M, Hong S P, Farrell C L, Pierce G F, Khouri R K. Platelet-derived growth factor BB induces functional vascular anastomoses in vivo.  Proc Natl Acad Sci USA,. 1995;  92 5920-5924
• 19 Pierce G F, Tarpley J E, Tseng J et al.. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds.  J Clin Invest. 1995;  96 1336-1350
• 20 Inkinen K, Wolff H, Lindroos P, Ahonen J. Connective tissue growth factor and its correlation to other growth factors in experimental granulation tissue.  Connect Tissue Res. 2003;  44 19-29
• 21 Pierce G F, Vande Berg J, Rudolph R, Tarpley J, Mustoe T A. Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosamingoglycans, collagen, and myofibroblasts in excisional wounds.  Am J Pathol. 1991;  138 629-646
• 22 Wang X T, Liu P Y, Tang J B. Tendon healing in vitro: genetic modification of tenocytes with exogenous PDGF gene and promotion of collagen gene expression.  J Hand Surg. 2004;  29A 884-890
• 23 Shore P, Sharrocks A D. Regulation of transcription by extracellular signals. In: Locker J Transcription Factors, 1st ed. San Diego; Academic Press 2001: 113-135
• 24 Parums D V, Cordell J L, Micklem K, Heryet A R, Gatter K C, Mason D Y. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections.  J Clin Pathol. 1990;  43 752-757
• 25 Richard L, Velasco P, Detmar M. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells.  Exp Cell Res. 1998;  240 1-6
• 26 Kangesu T, Manek S, Terenghi G et al.. Nerve and blood vessel growth in response to grafted dermis and cultured keratinocytes.  Plast Reconstr Surg. 1998;  101 1029-1038
• 27 Breitbart A S, Mason J M, Urmacher C et al.. Gene-enhanced tissue engineering: applications for wound healing using cultured dermal fibroblasts transduced retrovirally with the PDGF-B gene.  Ann Plast Surg. 1999;  43 632-639
• 28 Liechty K W, Nesbit M, Herlyn M, Radu A, Adzick N S, Grombleholme T M. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing.  J Invest Dermatol. 1999;  113 375-383
• 29 Sime P J, Marr R A, Gauldie D et al.. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta 1 and myofibroblasts.  Am J Pathol. 1998;  153 825-832